Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
作者信息
Pérez-Vizcaíno Francisco
机构信息
Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain; Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain.
出版信息
J Heart Lung Transplant. 2020 Oct;39(10):1167-1169. doi: 10.1016/j.healun.2020.07.003. Epub 2020 Jul 14.
Abstract
摘要
相似文献
1
Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?肺动脉高压中的肺血管紧张素转换酶2（ACE2）和肿瘤坏死因子α转换酶（ADAM17）：对2019冠状病毒病有何影响？
J Heart Lung Transplant. 2020 Oct;39(10):1167-1169. doi: 10.1016/j.healun.2020.07.003. Epub 2020 Jul 14.
2
COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.新型冠状病毒肺炎：血管紧张素1-7在血管紧张素转换酶2调节中的关键作用
Ann Acad Med Singap. 2020 Jun;49(6):398-400.
3
Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?用血管紧张素-（1-7）替代以预防新型冠状病毒感染中的肺损伤？
Circulation. 2020 May 26;141(21):1665-1666. doi: 10.1161/CIRCULATIONAHA.120.047297. Epub 2020 Apr 3.
4
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.血管紧张素转换酶 2 的器官保护作用及其对 COVID-19 预后的影响。
J Med Virol. 2020 Jul;92(7):726-730. doi: 10.1002/jmv.25785. Epub 2020 Apr 5.
5
SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.严重急性呼吸综合征冠状病毒2型发病机制：肾素-血管紧张素系统失衡促进肺纤维化。
Front Cell Infect Microbiol. 2020 Jun 12;10:340. doi: 10.3389/fcimb.2020.00340. eCollection 2020.
6
SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors.严重急性呼吸综合征冠状病毒2受体血管紧张素转换酶2基因表达与肾素-血管紧张素-醛固酮系统抑制剂
Lancet Respir Med. 2020 Jun;8(6):e50-e51. doi: 10.1016/S2213-2600(20)30224-1. Epub 2020 May 13.
7
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.血管紧张素转换酶 2：SARS-CoV-2 受体和肾素-血管紧张素系统的调节剂：庆祝 ACE2 发现 20 周年。
Circ Res. 2020 May 8;126(10):1456-1474. doi: 10.1161/CIRCRESAHA.120.317015. Epub 2020 Apr 8.
8
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.心肺疾病中的 ACE2（血管紧张素转换酶 2）：对 SARS-CoV-2 控制的影响。
Hypertension. 2020 Sep;76(3):651-661. doi: 10.1161/HYPERTENSIONAHA.120.15595. Epub 2020 Aug 12.
9
Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与血管紧张素转换酶2的结合：临床意义
Cardiovasc Res. 2020 Jun 1;116(7):e87-e89. doi: 10.1093/cvr/cvaa096.
10
Coronavirus SARS-Cov-2 and arterial hypertension - facts and myths.新型冠状病毒SARS-CoV-2与动脉高血压——事实与误解
Pol Merkur Lekarski. 2020 Jun 17;48(285):195-198.
引用本文的文献
1
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities.新型冠状病毒感染对肺血管的潜在长期影响：合并感染和合并症背景下的多层次串扰。
PLoS Pathog. 2023 Jan 12;19(1):e1011063. doi: 10.1371/journal.ppat.1011063. eCollection 2023 Jan.
2
Potential Similarities in Sex Difference in Key Genes and Their Expression, Network, EQTL and Pathways between COVID-19 and Chronic Kidney Disease Based on Mouse Model.基于小鼠模型的新冠病毒病与慢性肾脏病关键基因及其表达、网络、表达数量性状基因座和信号通路中性别差异的潜在相似性
J Pers Med. 2022 Jul 21;12(7):1190. doi: 10.3390/jpm12071190.
3
Neurohormonal modulation in pulmonary arterial hypertension.肺动脉高压中的神经激素调节。
Eur Respir J. 2021 Oct 28;58(4). doi: 10.1183/13993003.04633-2020. Print 2021 Oct.
本文引用的文献
1
Prognostic value of NT-proBNP in patients with severe COVID-19.NT-proBNP 对重症 COVID-19 患者的预后价值。
Respir Res. 2020 Apr 15;21(1):83. doi: 10.1186/s12931-020-01352-w.
2
Angiotensin converting enzyme 2 and angiotensin (1-7) axis in pulmonary arterial hypertension.肺动脉高压中的血管紧张素转换酶2与血管紧张素（1-7）轴
Eur Respir J. 2020 Jul 23;56(1). doi: 10.1183/13993003.02416-2019. Print 2020 Jul.
3
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.SARS-CoV-2 及其他 B 属β冠状病毒的细胞进入和受体使用功能评估。
Nat Microbiol. 2020 Apr;5(4):562-569. doi: 10.1038/s41564-020-0688-y. Epub 2020 Feb 24.
4
Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.血管紧张素转换酶2作为预防肺动脉高压治疗靶点的证据。
Am J Respir Crit Care Med. 2009 Jun 1;179(11):1048-54. doi: 10.1164/rccm.200811-1678OC. Epub 2009 Feb 26.
5
Angiotensin-converting enzyme 2 protects from severe acute lung failure.血管紧张素转换酶2可预防严重急性肺衰竭。
Nature. 2005 Jul 7;436(7047):112-6. doi: 10.1038/nature03712.
Zotero 插件